Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Franken, MG"'
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
In Value in Health November 2015 18(7):A440-A440
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
In Value in Health November 2015 18(7):A440-A441
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
Value in Health. (7):A440-A441
Autor:
Leeneman, B, Franken, MG, Jochems, A, Schouwenburg, MG, Wouters, MW, Van den Eertwegh, AJ, Haanen, JB, Van der Hoeven, KJ, Uyl - de Groot, CA
Publikováno v:
Value in Health. (7):A440
Autor:
Leeneman, B1, Franken, MG2, Jochems, A3, Schouwenburg, MG4, Wouters, MW5, Van den Eertwegh, AJ6, Haanen, JB5, Van der Hoeven, KJ3, Uyl - de Groot, CA2, Franken, M G2 (AUTHOR), Schouwenburg, M G4 (AUTHOR), Wouters, M W5 (AUTHOR), Van den Eertwegh, A J6 (AUTHOR), Haanen, J B5 (AUTHOR), Van der Hoeven, K J3 (AUTHOR), Uyl-de Groot, C A2 (AUTHOR)
Publikováno v:
Value in Health. Nov2015, Vol. 18 Issue 7, pA440-A440. 1p.
Autor:
Leeneman, B1, Franken, MG2, Jochems, A3, Schouwenburg, MG4, Wouters, MW5, Van den Eertwegh, AJ6, Haanen, JB5, Van der Hoeven, KJ3, Uyl - de Groot, CA2, Franken, M G2 (AUTHOR), Schouwenburg, M G4 (AUTHOR), Wouters, M W5 (AUTHOR), Van den Eertwegh, A J6 (AUTHOR), Haanen, J B5 (AUTHOR), Van der Hoeven, K J3 (AUTHOR), Uyl-de Groot, C A2 (AUTHOR)
Publikováno v:
Value in Health. Nov2015, Vol. 18 Issue 7, pA440-A441. 1p.
Autor:
Heine RJSD; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands., Thielen FW; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, Rotterdam, The Netherlands., van Leeuwen RWF; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Rotterdam, The Netherlands., Franken MG; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands., Uyl-de Groot CA; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
PloS one [PLoS One] 2024 Feb 01; Vol. 19 (2), pp. e0293264. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Autor:
Blankenstein SA; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands. s.blankenstein@nki.nl., Bonenkamp JJ; Department of Surgical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Centre Geleen-Heerlen, Sittard-Geleen, The Netherlands., Blank CU; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU University Medical Center (VUmc), Amsterdam, The Netherlands., Franken MG; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands., de Groot JWB; Oncology Center Isala, Isala, Zwolle, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kapiteijn EW; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., van Not OJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., van der Veldt AAM; Departments of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Wouters MWJM; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Jan; Vol. 30 (1), pp. 573-586. Date of Electronic Publication: 2022 Oct 06.
Autor:
Franken MG; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: franken@imta.eur.nl., Leeneman B; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., de Groot JWB; Oncology Center Isala, Isala, Zwolle, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Wouters MWJM; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
ESMO open [ESMO Open] 2021 Dec; Vol. 6 (6), pp. 100320. Date of Electronic Publication: 2021 Nov 29.
Autor:
Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, the Netherlands. Electronic address: leeneman@eshpm.eur.nl., Schreuder K; Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands., Uyl-de Groot CA; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, the Netherlands; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, the Netherlands., van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Wakkee M; Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands., Franken MG; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, the Netherlands; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, the Netherlands., Louwman MWJ; Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Sep; Vol. 154, pp. 111-119. Date of Electronic Publication: 2021 Jul 10.